Dec. 8 at 2:07 PM
$COGT $AVGO $CRWV $MRVL $TSLA
PRE-MARKET MOVERS:
Currently Higher:
- Kymera Therapeutics (KYMR) up 35.9% after reporting clinical results from the BroADen Phase 1b atopic dermatitis clinical trial of KT-621
- Cogent Biosciences (COGT) up 12.6% after announcing results of APEX trial of bezuclastinib
- Confluent (CFLT) up 29.4% after entering into a definitive agreement under which IBM (IBM) will acquire all of the issued and outstanding common shares of the company for
$31 per share
- Broadcom (AVGO) up 3.5% after The Information reported Microsoft (MSFT) is in talks to design custom chips with Broadcom, switching its business from Marvell (MRVL)
Currently Lower:
- Marvell (MRVL) down 7.1% after the report that Microsoft (MSFT) is in talks to design custom chips with Broadcom, switching its business from the company
- CoreWeave (CRWV) down 4.1% after
$2B convertible debt offering
- Agios Pharmaceuticals (AGIO) down 1.2% after announcing that the FDA has not yet issued a regulatory decision on the supplemental new drug application for mitapivat for the treatment of adult patients with non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia and that the sNDA remains under active review
- Tesla (TSLA) down 1.4% after Morgan Stanley downgraded the stock to Equal Weight from Overweight with a price target of
$425, up from
$410, as a new analyst took over coverage
- ITT (ITT) down 1.8% after 7M share common stock offering
